Headache symptoms of the PREEMPT population

Lignende værker

• OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
  af: Aurora, SK, et al.
  Udgivet: (2013)
• OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
  af: Diener, HC, et al.
  Udgivet: (2013)
• The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
  af: Silberstein, S, et al.
  Udgivet: (2013)
• OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT
  af: Dodick, D, et al.
  Udgivet: (2013)
• OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
  af: Aurora, SK, et al.
  Udgivet: (2014)